BioMarin Pharmaceutical Inc. (BMRN) announced plans to offer $850 million in senior unsecured notes due 2034 in a private offering.

Johnson & Johnson (JNJ) reported strong Q4 and full-year 2025 results, exceeding expectations with 9.1% reported sales growth in Q4 and 6.0% for the full year.